Mahaley M S, Gentry R E, Bigner D D
J Neurosurg. 1977 Jul;47(1):35-43. doi: 10.3171/jns.1977.47.1.0035.
The avian sarcoma virus-induced glioma model in rats was used to study the effectiveness of immunotherapy, namely, Bacillus Calmette-Guérin (BCG) with or without sarcoma cells and/or chemotherapy with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU), upon survival times. The most consistent prolongation of survival time was produced by triple therapy: BCG + intraperitoneally administered sarcoma cells + intravenously administered BCNU.
利用禽肉瘤病毒诱导的大鼠胶质瘤模型,研究免疫疗法(即卡介苗(BCG)联合或不联合肉瘤细胞)和/或化疗药物1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)对生存期的影响。三联疗法(BCG + 腹腔注射肉瘤细胞 + 静脉注射BCNU)使生存期延长最为稳定。